Fibrosis is characterized by fibroblast activation, extracellular matrix (ECM) accumulation
and infiltration of inflammatory cells that sometimes leads to irreversible organ dysfunction …

Serum Markers Of Disease Progression In Idiopathic Pulmonary Fibrosis And In Interstitial Lung
Disease Associated With Systemic Page 1 / Poster Discussion Session / A23 IDIOPATHIC …

Rationale: Idiopathic Pulmonary Fibrosis (IPF) is often diagnosed late in the disease course
after significant functional lung tissue has been destroyed. Approved therapies do not …

Extract Idiopathic pulmonary fibrosis (IPF) is a chronic debilitating lung disease,
characterised by progressive deposition of excessive extracellular matrix in the lung …

Objective: To evaluate the association of S100A4 levels with the prognosis of lung cancer
(LC). Methods: The RevMan 5.0 software was utilized to perform literature retrieval, data …

S100 proteins have been implicated in the progression and metastasis of several cancers.
Among the S100 family, S100A9 is reportedly expressed in non-small cell lung cancer …

RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a devastating fibrosing pulmonary
disease with unknown etiology, and its median survival time is reported to be about 3 years …

Nintedanib is now used worldwide as an antifibrotic drug to treat patients with idiopathic
pulmonary fibrosis (IPF). In INPULSIS-2 (Safety and Efficacy of BIBF 1120 at High Dose in …

Rationale Idiopathic pulmonary fibrosis (IPF) is a very rapidly progressing interstitial lung
disease. Non-invasive biomarkers are needed to estimate individual disease behavior and …

RATIONALE: Idiopathic pulmonary fibrosis (IPF) is typically a progressive disease, although
the progression of the disease can vary. Numerous unique genes have been discovered in …